Cetera Investment Advisers
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1666741
SCHAUMBURG, IL
Position in TAK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,148,757
+$891,664 QoQ
Shares Held
224,015
+7.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $48,125,230 across 32 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
80,566 | $9,523,706 | |
| 2 | VTRS |
Viatris Inc
|
385,999 | $5,214,846 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
8,648 | $5,128,091 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
224,015 | $4,148,757 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
121,502 | $2,907,542 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
20,245 | $2,667,076 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,216 | $2,626,945 | |
| 8 | HLN |
Haleon plc
|
247,741 | $2,479,887 |
All Filings in TAK
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,148,757 | 224,015 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,257,093 | 208,922 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,121,467 | 213,215 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,151,785 | 74,501 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,118,774 | 75,237 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $784,774 | 59,273 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $735,159 | 51,699 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $540,814 | 41,794 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $508,276 | 36,593 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $194,642 | 13,640 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $229,791 | 14,854 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $233,921 | 14,890 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $263,795 | 16,007 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||